Drug Development
Alumis Secures Record-Breaking $259M Series C Financing for Precision Immunology Drug Development
Alumis, Series C funding, $259 million, Precision immunology, Drug development, Private biotech fundraise
Actionable Insights Powered by AI
Alumis, Series C funding, $259 million, Precision immunology, Drug development, Private biotech fundraise